Use of convalescent plasma in COVID‐19 patients with immunosuppression

In the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel coronavirus disease 19 (COVID‐19), including among patients with innate or acquired immunosuppression. However, the assoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transfusion
Hauptverfasser: Senefeld, Jonathon W., Klassen, Stephen A., Ford, Shane K., Senese, Katherine A., Wiggins, Chad C., Bostrom, Bruce C., Thompson, Michael A., Baker, Sarah E., Nicholson, Wayne T., Johnson, Patrick W., Carter, Rickey E., Henderson, Jeffrey P., Hartman, William R., Pirofski, Liise‐anne, Wright, R. Scott, Fairweather, De Lisa, Bruno, Katelyn A., Paneth, Nigel S., Casadevall, Arturo, Joyner, Michael J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2021
Schlagworte:
Reviews
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242637/
https://ncbi.nlm.nih.gov/pubmed/34036587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16525
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge